Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Bausch Health Companies Inc. BHC
$5.65
-$0.17 (-3.00%)
На 18:01, 12 мая 2023
+59.29%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
2129604020.00000000
-
week52high
11.34
-
week52low
4.00
-
Revenue
8124000000
-
P/E TTM
-10
-
Beta
0.97716200
-
EPS
-0.63000000
-
Last Dividend
6.42500000
-
Next Earnings Date
04 мая 2023 г. в 12:30
Описание компании
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | 01 сент 2022 г. |
| RBC Capital | Sector Perform | Sector Perform | 10 авг 2022 г. |
| BMO Capital | Market Perform | Market Perform | 10 авг 2022 г. |
| Truist Securities | Hold | Buy | 29 июл 2022 г. |
| RBC Capital | Sector Perform | Outperform | 29 июл 2022 г. |
| Piper Sandler | Neutral | Neutral | 09 сент 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Vadaketh Tom George | D | 470204 | 6310 | 03 янв 2023 г. |
| DE SCHUTTER RICHARD U | A | 369765 | 5186 | 30 дек 2022 г. |
| ICAHN BRETT | A | 60190 | 4589 | 30 дек 2022 г. |
| Miller Steven D | A | 110312 | 4589 | 30 дек 2022 г. |
| ROBERTSON RUSSEL C | A | 177416 | 5473 | 30 дек 2022 г. |
| Paulson John | A | 142290 | 9952 | 30 дек 2022 г. |
| WECHSLER AMY B | A | 136654 | 1094 | 30 дек 2022 г. |
| Carson Seana | D | 361719 | 1691 | 01 дек 2022 г. |
| Carson Seana | D | 363410 | 334 | 03 ноя 2022 г. |
| ROBERTSON RUSSEL C | A | 171943 | 4989 | 30 сент 2022 г. |
Новостная лента
Bausch Health: Bullish On Long-Term Prospects, Awaiting Subsiding Headwinds
Seeking Alpha
10 мая 2023 г. в 08:44
Bausch Health has been through rough times, leading to skepticism among investors. Its investment potential, however, has been on the upswing since 2016, when Joseph Papa took over as CEO.
Bausch Health's (BHC) Q1 Earnings & Sales Miss, Shares Down
Zacks Investment Research
05 мая 2023 г. в 14:27
Bausch (BHC) declines as it misses on earnings and sales in the first quarter.
Bausch (BHC) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research
04 мая 2023 г. в 12:12
The headline numbers for Bausch (BHC) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Bausch Health to Announce First-Quarter 2023 Results on May 4
Accesswire
13 апр 2023 г. в 08:00
LAVAL, QC / ACCESSWIRE / April 13, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release its first-quarter financial results on Thursday, May 4, 2023. Bausch Health will host a conference call and live webcast at 8:00 a.m.
Bausch Health: Full Bausch + Lomb Spin-Off Finally Seems Close
Seeking Alpha
27 февр 2023 г. в 18:17
Bausch + Lomb Corporation recently appointed a new high-profile CEO in Brent Saunders. Bausch Health Companies Inc. has hit the internal metrics necessary to justify spinning off more Bausch + Lomb shares.